27 web-programmer-developer-university-of-liverpool PhD positions at University of Cambridge
Sort by
Refine Your Search
-
Funder: Astra Zeneca Duration: 4 years from October 1st 2026 Supervisors: Prof Paul Midgley (University of Cambridge) and Dr Okky Putra (Astra Zeneca) Location: The studentship will be based in
-
Location: West Cambridge Funder: Tata Steel and the University of Cambridge Duration: 4 years from 1 October 2026 Supervisors: Prof Howard Stone and Dr David Collins Location: The PhD studentship
-
non-clinical PhD studentship in cardiometabolic research, commencing October 2026 in the Department of Medicine (VPD Heart & Lung Research Institute), University of Cambridge. The project will be based
-
increasing pressure to reduce its carbon footprint while ensuring long-term performance of infrastructure, particularly in environments that accelerate material degradation. This PhD aims to develop and
-
. There�s now a pressing need to understand how these symbionts affect development and fitness. This project tackles a key evolutionary ecology question: when are gut microbes are important for wildlife
-
their properties, as well as develop ways to manipulate and advance the nano-assembly processes. You would also be involved in scale-up on roll-to-roll pre-pilot kit, to explore applications for these advanced
-
both chemistry and biology to explore fundamental mechanisms of genome function (http://www.balasubramanian.co.uk ). Our projects involve developing and using cutting edge technologies in chemical
-
Applications are invited for a fully funded 4-year PhD studentship based in the Department of Biochemistry, University of Cambridge, and the new AstraZeneca Discovery Centre in Cambridge
-
to cancer biology, as well as a strong commitment of developing and using new tools to address cutting-edge questions in these fields. This studentship is embedded within the piRNA team, consisting of both
-
target, since all known treatment resistance mechanisms are downstream of, and dependent on FOXA1. However, FOXA1 has been a difficult protein to study for technical reasons. We have developed a novel tool